- Home
- / Op2Lysis
Op2Lysis
Op2Lysis Summary
Company Summary
- Overview
- Op2Lysis is a biotechnology company developing a drug treatment for hemorrhagic stroke. Its product O2L-001 is a thrombolytic agent intended to liquefy the intracerebral hematoma that formed following a hemorrhagic stroke.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Boulogne-Billancourt, FR | view all locations
- Website
- https://www.op2lysis.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Boulogne-Billancourt, IDF HQ
France
117 Avenue Victor Hugo
Competitors and Similar Companies
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026